Literature DB >> 3098409

Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.

C W Song, I Lee, T Hasegawa, J G Rhee, S H Levitt.   

Abstract

The potential usefulness of i.v. injection of perfluorochemicals and breathing carbogen (95% O2 and 5% CO2) to improve the radiation-induced control of tumors was investigated. When C3H mice, bearing RIF-1 tumors in the legs, were given i.v. injections of Fluosol-DA (20%) at 12 ml/kg, and allowed to breathe carbogen for 1 h before and during a single dose of X-irradiation, the curability of tumors increased by a dose modification factor of 1.47 +/- 0.03 (SE). Such a treatment also increased the radiation-induced skin damage by a factor of 1.15 +/- 0.12, resulting in a therapeutic gain of 1.28 +/- 0.04. Measurement of intratumor pO2 by oxygen microelectrodes demonstrated small increases in pO2 when the animals breathed carbogen, and marked increases in pO2 when Fluosol-DA (20%) was injected into the animals and the animals breathed carbogen. It was concluded that i.v. injection of Fluosol-DA (20%) followed by carbogen breathing significantly improved the oxygen supply to hypoxic cells in the RIF-1 tumors and thus increased the control of tumors by radiation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3098409

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Tumour pO2 can be increased markedly by mild hyperthermia.

Authors:  K Iwata; A Shakil; W J Hur; C M Makepeace; R J Griffin; C W Song
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content.

Authors:  M W Dewhirst; E T Ong; G L Rosner; S W Rehmus; S Shan; R D Braun; D M Brizel; T W Secomb
Journal:  Br J Cancer Suppl       Date:  1996-07

3.  The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo.

Authors:  G E Kim; C W Song
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.

Authors:  B A Teicher; T S Herman; J Tanaka; B Dezube; A Pardee; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 5.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

6.  Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.

Authors:  B A Teicher; T S Herman; R E Hopkins; K Menon
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

7.  The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging.

Authors:  S P Robinson; L M Rodrigues; A S Ojugo; P M McSheehy; F A Howe; J R Griffiths
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.

Authors:  D J Chaplin; M R Horsman; D W Siemann
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

9.  Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.

Authors:  D J Chaplin; M R Horsman; D S Aoki
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

10.  The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618a.

Authors:  M Stubbs; S P Robinson; L M Rodrigues; C S Parkins; D R Collingridge; J R Griffiths
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.